One-Step RT-qPCR Kits Market
One-Step RT-qPCR Kits Market Overview 2025 to 2035
The one-step RT-qPCR kits market is projected to witness significant growth, fueled by advancements in molecular diagnostics, increasing demand for rapid testing, and expansion in research applications. Between 2025 and 2035, the market is expected to grow at a CAGR of 5.9%, reaching USD 191 million by 2035, up from USD 112.1 million in 2025.
| Attributes |
Key Statistics |
|---|---|
|
Expected Base Year Value (2025) |
USD 112.1 million |
|
Anticipated Forecast Value (2035) |
USD 191 million |
|
Estimated Growth (2025-2035) |
5.9% CAGR |
Market Growth Drivers
- Rising Prevalence of Infectious Diseases – Increasing demand for fast and accurate diagnostic solutions.
- Expansion in Genetic Research & Drug Discovery – Increasing applications in cancer research, biomarker discovery, and virology.
- Adoption in Point-of-Care Testing (POCT) – Growing focus on rapid and field-deployable testing solutions.
- Integration of AI & Automation in Diagnostics – Enhanced efficiency and accuracy in RT-qPCR workflows.
- Multiplexing Capabilities & High-Throughput Testing – Growing demand for assays that can detect multiple pathogens simultaneously.
Market Segmentation
By Reaction Volume
| Reaction Type |
Market Share (2025) |
|---|---|
|
25 Rxn Kits |
15% |
|
50 Rxn Kits |
25% |
|
100 Rxn Kits |
30% |
|
200 Rxn & Above Kits |
30% |
By End-User
| End-User |
Market Share (2025) |
|---|---|
|
Hospitals & Clinical Laboratories |
45% |
|
Research Institutes & Universities |
35% |
|
Biotechnology & Pharmaceutical Companies |
20% |
Geographical Insights
| Country |
CAGR (2025-2035) |
|---|---|
|
United States |
4.5% |
|
Germany |
5.2% |
|
France |
5.0% |
|
China |
6.3% |
|
India |
7.8% |
- North America: Dominates due to strong research infrastructure and technological advancements.
- Europe: Growth fueled by rising government investments in life sciences.
- Asia-Pacific: Emerging as a key market due to increasing investments in molecular diagnostics.
Challenges & Restraints
- Competition from Alternative Technologies – Advancements in CRISPR-based diagnostics and Next-Generation Sequencing (NGS).
- High Costs of RT-qPCR Equipment & Reagents – Barriers to adoption in developing economies.
- Regulatory Hurdles & Approval Timelines – Compliance with stringent healthcare regulations.
Competitive Landscape & Key Players
The one-step RT-qPCR kits market is led by established players and emerging biotechnology firms. Leading companies include:
- Thermo Fisher Scientific Inc.
- QIAGEN
- Bio-Rad Laboratories, Inc.
- Takara Bio Inc.
- Promega Corporation
- New England Biolabs
- Fortis Life Sciences
Recent Developments
- January 2025 – QIAGEN launched next-gen multiplex RT-qPCR assays for high-throughput diagnostics.
- September 2024 – Bio-Rad Laboratories introduced portable qPCR platforms for field-based applications.
- June 2024 – Thermo Fisher announced strategic partnerships for automated molecular testing solutions.
Frequently Asked Questions (FAQs)
Q1: What is the projected market size of one-step RT-qPCR kits in 2025?
A: The market is expected to reach USD 112.1 million in 2025.
Q2: How fast is the one-step RT-qPCR kits market growing?
A: The market is expanding at a CAGR of 5.9% from 2025 to 2035.
Q3: Which companies dominate the one-step RT-qPCR kits market?
A: Key players include Thermo Fisher Scientific, QIAGEN, Bio-Rad Laboratories, and Takara Bio Inc..
Conclusion & Call to Action
The one-step RT-qPCR kits market is on an upward trajectory, driven by technological advancements and increasing applications in diagnostics and research. Companies investing in automation, multiplexing, and high-throughput testing are positioned for sustained market leadership.
Take action now! Contact us today to access the full report and propel your business forward.